
Johnson & Johnson will provide up to 200,000 Ebola vaccines to the Republic of Rwanda, through its pharmaceutical subsidiary Janssen. …

The World Health Organisation (WHO) has accepted MSD’s application for the company’s investigational Ebola vaccine, V920 (Zebov), to be reviewed …

An experimental antiviral therapy may have prevented British healthcare workers from contracting Ebola after exposure to the disease in West …

The first trial of an experimental Ebola vaccine suggests it provides high protection against the disease as early as ten …

